{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://urn.fi/URN:NBN:fi:au:cn:52085A",
      "@type": "Organization",
      "name": "Algol. Lääkeosasto"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00321063200",
      "contributor": {
        "@id": "http://urn.fi/URN:NBN:fi:au:cn:52085A"
      },
      "name": "Paniikkihäiriö : etiologia ja diagnostiikka"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00087766300",
      "contributor": {
        "@id": "http://urn.fi/URN:NBN:fi:au:cn:52085A"
      },
      "name": "Moxonidine in the regulation of sympathetic overactivity, high blood pressure and insuline resistance : Solvay Pharma symposium on moxonidine, Wasa Queen, September 19, 1997 : programme & abstracts"
    }
  ]
}